Hillenbrand (NYSE:HI) Bolsa

HILLENBRAND INC

Hillenbrand

Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.

News

Management

CORRECTION: Hillenbrand Appointed Megan Walke, To Serve As The Interim CFO, Effective June 28, 2025

Hillenbrand, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) announced today that Robert "Bob" VanHimbergen, Senior Vice President and Chief Financial Officer, has decided to take another position outside of the company, effective June 27, 2025.
Upon Mr. VanHimbergen's departure, Megan Walke, Vice President, Corporate Controller and Chief Accounting Officer (CAO), will serve as Interim CFO. Ms. Walke has been with Hillenbrand for 14 years, holding key financial leadership roles, including as CAO since May 2022, and formerly worked in public accounting for nine years. The company has engaged a leading executive search firm to conduct a comprehensive search for a permanent CFO.

Hillenbrand Announces Robert "Bob" Vanhimbergen, Senior Vice President And CFO, Has Decided To Take Another Position Outside Of The Company, Effective June 27, 2025; Megan Walke, Vice President, Corporate Controller And Chief Accounting Officer, Will Serve As Interim CFO

WIIM

AGCO

ATMU

CMCO

GTES

GTLS

HLMN

INLF

LECO

MIDD

NDSN

PCAR

RAIL

RAIN

Shares of machinery companies are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A reduction in tariffs could alleviate some supply chain concerns and improve macro sentiment as well as demand visibility.

Keybanc analyst Jeffrey Hammond downgrades Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) from Overweight to Sector Weight.

Downgrades

Analyst Ratings

Keybanc Downgrades Hillenbrand to Sector Weight

DA Davidson analyst Matt Summerville maintains Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) with a Neutral and lowers the price target from $33 to $24.

Price Target

DA Davidson Maintains Neutral on Hillenbrand, Lowers Price Target to $24

Hillenbrand shares are trading lower after the company reported Q2 financial results and issued Q3 guidance below estimates. Also, the company cut its FY25 guidance below estimates.

Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) lowers FY2025 Adj EPS guidance from $2.45-$2.80 to $2.10-$2.45 vs $2.48 analyst estimate. Lowers FY2025 sales outlook from $2.63 billion-$2.79 billion to $2.56 billion-$2.62 billion vs $2.66 billion estimate.

Guidance

Hillenbrand Lowers FY2025 Adj EPS Guidance from $2.45-$2.80 to $2.10-$2.45 vs $2.48 Est; Lowers FY2025 Sales Guidance from $2.63B-$2.79B to $2.56B-$2.62B vs $2.66B Est

Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) is looking for Q3 Adj EPS of $0.46-$0.53 vs $0.65 analyst estimate. sees sales of $569.000 million-$583.000 million vs $611.74 million analyst estimate.

Hillenbrand Sees Q3 Adj EPS $0.46-$0.53 vs $0.65 Est; Sees Sales $569.000M-$583.000M vs $611.74M Est

Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.54 by 11.11 percent. This is a 21.05 percent decrease over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $715.90 million which beat the analyst consensus estimate of $691.00 million by 3.60 percent. This is a 8.84 percent decrease over sales of $785.30 million the same period last year.

Earnings

Earnings Beats

Hillenbrand Q2 Adj. EPS $0.60 Beats $0.54 Estimate, Sales $715.90M Beat $691.00M Estimate

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CECO

CHCT

CLVT

CSGP

CVLT

DHIL

ENSG

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Hillenbrand to report an earnings per share (EPS) of $0.54.
Hillenbrand bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 7.3% drop in the share price the next day.
Here's a look at Hillenbrand's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.54</td>
<td>0.92</td>
<td>0.82</td>
<td>0.75</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.56</td>
<td>1.01</td>
<td>0.85</td>
<td>0.76</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-7.000000000000001%</td>
<td>12.0%</td>
<td>-4.0%</td>
<td>-13.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745866927_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Hillenbrand were trading at $22.52 as of April 25. Over the last 52-week period, shares are down 53.23%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/HI/earnings">To track all earnings releases for Hillenbrand visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse of Hillenbrand's Earnings Potential

CVGI

HLIO

JBTM

TWIN

Shares of machinery companies are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

ALSN

BLBD

EPAC

ESAB

FSTR

OTIS

PDYN

PRLB

SPXC

UGRO

WPRT

Shares of machinery companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Shares of StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter <a href="https://www.benzinga.com/quote/STNE/earnings">earnings and sales results</a>.
StoneCo shares jumped 8% to $10.64 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Leishen Energy Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSE#NASDAQ">LSE</a>) gained 90% to $14.31 in pre-market trading after jumping over 46% on Tuesday. The company recently reported FY24 financial results.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) rose 35.4% to $0.1760 in pre-market trading after the company announced positive results from a beagle dog dose range-finding study.</li>
<li>TEN Holdings, Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) gained 34% to $0.7839 in pre-market trading. TEN Holdings shares jumped 18% on Tuesday after the company announced a $1 million stock repurchase program.</li>
<li>Aterian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) gained 27% to $2.68 in pre-market after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Bowen Acquisition Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOWN#NASDAQ">BOWN</a>) gained 24% to $5.43 in pre-market trading after jumping 5% on Tuesday.</li>
<li>CARGO Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) gained 21.1% to $4.60 in pre-market trading after the company suspended CRG-023 &amp; allogeneic platform and initiated 90% workforce reduction.</li>
<li>Hillenbrand, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) gained 17.3% to $29.29 in pre-market trading.</li>
<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) rose 11.8% to $1.32 in pre-market trading after dipping 23% on Tuesday.</li>
<li>CNS Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) rose 10.4% to $3.92 after surging 16% on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>FST Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBSX#NASDAQ">KBSX</a>) fell 23.1% to $4.22 in pre-market trading after gaining 310% on Tuesday.</li>
<li>5E Advanced Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEAM#NASDAQ">FEAM</a>) shares fell 21.2% to $3.08 in pre-market trading after gaining 5% on Tuesday.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) fell 18.5% to $0.2012 in pre-market trading after gaining around 22% on Tuesday. Starbox Group company received staff determination notice from Nasdaq.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) declined 16.1% to $26.50 in pre-market trading after climbing 70% on Tuesday.</li>
<li>OSR Holdings, Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSRH#NASDAQ">OSRH</a>) dipped 15.5% to $1.51 in pre-market trading after jumping 34% on Tuesday.</li>
<li>Turkcell Iletisim Hizmetleri A.S. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKC#NYSE">TKC</a>) shares tumbled 14.8% to $6.43 in pre-market trading.</li>
<li>HealthEquity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) shares fell 14.7% to $86.68 in pre-market trading after the company reported worse-than-expected quarterly earnings results.</li>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) shares dipped 13% to $17.87 in pre-market trading following weak quarterly sales.</li>
<li>Absci Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>) fell 9.4% to $2.79 in today's pre-market trading after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Waterdrop Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) fell 6.5% to $1.30 in pre-market trading after declining around 5% on Tuesday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44375233/top-3-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>
Photo: Shutterstock

Pre-Market Outlook

Markets

Movers

Trading Ideas

ABSI

ATER

BOWN

CNSP

CRGX

FEAM

KBSX

OSRH

STBX

STNE

TNXP

VRPX

XHLD

Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

<h2 class="wp-block-heading">New On The Block</h2>
PharmChem, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PCHM#OTC">PCHM</a>), the go-to name for drug-detecting sweat patches, is officially exploring strategic alternatives (i.e., mergers, acquisitions, or an outright sale). So far, the board of directors expressed confidence that it can handle things solo as opposed to hiring a banker. For interested suitors, a <a href="https://www.benzinga.com/topic/mergers-and-acquisitions">data room officially opened</a>.
Other auction block items this week:
<ul>
<li>Ontario Teachers&#8217; Pension Plan tapped Lazard to run a sale process for compliance software firm Mitratech. Reuters estimates that the transaction could hover around $4 billion.</li>
<li>Recall how Paysafe (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSFE#NYSE">PSFE</a>) went public <a href="https://www.benzinga.com/news/20/12/18678982/paysafe-goes-public-again-in-spac-deal-what-investors-should-know">via a SPAC in 2020</a>. Today, it&#8217;s for sale, according to <a href="https://www.bloomberg.com/news/articles/2025-02-06/paysafe-is-said-to-weigh-sale-after-getting-takeover-interest?srnd=phx-deals">Bloomberg</a>. The firm, backed by billionaire Bill Foley, is receiving takeover interest.</li>
<li>Switzerland-based Bank J. Safra Sarasin is weighing a takeover offer for Denmark&#8217;s Saxo Bank, per <a href="https://www.bloomberg.com/news/articles/2025-02-03/safra-sarasin-is-said-to-explore-deal-for-denmark-s-saxo-bank?srnd=phx-deals">Bloomberg</a>.</li>
</ul>
<h2 class="wp-block-heading">Updates From The Block</h2>
<ul>
<li>Veritas Capital is circling Wall Street data provider Dun &amp; Bradstreet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNB#NYSE">DNB</a>), per <a href="https://www.bloomberg.com/news/articles/2025-02-07/veritas-is-said-in-talks-to-acquire-data-firm-dun-bradstreet?srnd=phx-deals">Bloomberg</a>. Dun &amp; Bradstreet boasts a $4.9 billion market cap.</li>
<li>Bausch + Lomb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) considered &#8220;a full separation&#8221; from Bausch Health Companies Inc. After engaging with potential buyers, that process did not result in a deal. Full separation remains the goal, the company confirmed. Full-year 2024 earnings will be posted on Feb. 19.</li>
<li>KKR &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) is adamant about buying Japanese tech group Fuji Soft. The private equity firm upped its offer to around $4.3 billion to outbid a rival firm, Bain Capital.</li>
<li>Bain has another deal in the works, should the Fuji Soft one not work out. The firm is close to buying the pharma unit of Mitsubishi Chemical Group (TYO:<a class="ticker" href="https://www.benzinga.com/stock/TYO:4188#TYO">4188</a>). The price tag is expected to be north of $3.3 billion, according <a href="https://www.bloomberg.com/news/articles/2025-02-06/bain-is-said-to-near-3-billion-deal-for-mitsubishi-pharma-unit?srnd=phx-deals">to</a> Bloomberg.</li>
</ul>
<h2 class="wp-block-heading">Off The Block</h2>
<ul>
<li>Meanwhile, Bain Capital <a href="https://www.plasticsnews.com/news/hillenbrand-sells-majority-stake-milacron-bain-capital-287m">agreed</a> to buy a 51% stake in Milacron, a provider of plastic processing equipment and services. Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) sold the stake for $287 million. </li>
<li>Riverwood Capital agreed to <a href="https://en.globes.co.il/en/article-riverwood-capital-buys-israeli-ai-pricing-co-quicklizard-1001501462">buy</a> Munich-based Quicklizard (TASE: QLRD), a pricing platform for retailers and brands, for roughly $52 million.</li>
<li>TPG <a href="https://www.benzinga.com/25/02/43537313/why-altus-power-stock-is-gaining-today">agreed to buy</a> Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>), an owner of commercial-scale solar in the U.S., for around $2.2 billion.</li>
<li>Another solar-related deal: Turn/River Capital agreed to buy Austin, Texas-based SolarWinds (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWI#NYSE">SWI</a>) for $4.4 billion — a 35% premium to the stock&#8217;s closing price on Thursday, Feb. 6.</li>
<li>Montreal-basedValsoft, a software firm backed by Coatue Management and Viking Global Investors, acquired VHL Sistemas, a Brazilian provider of cloud-based notary management software.</li>
<li>BCI, a Canadian asset management, agreed to buy Luxembourg-based investment BBGI Global Infrastructure (LSE: BBGIB). Reuters reported that the deal cost around 1 billion pounds ($1.24 billion).</li>
<li>EP Global Commerce, backed by billionaire Daniel Kretinsky, <a href="https://www.bloomberg.com/news/articles/2025-02-06/czech-billionaire-kretinsky-seeks-to-take-metro-private-again?srnd=phx-deals">purchased</a> Düsseldorf, Germany-based Metro at a 2 billion euro ($2.76 billion) valuation. </li>
<li>Databricks, valued at $62 billion, <a href="https://www.infoworld.com/article/3817328/databricks-acquires-bladebridge-to-aid-data-warehouse-migrations.html">acquired</a> BladeBridge and its talent to bolster enterprise data warehouse migrations.</li>
<li>JD.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) reportedly revived its interest in buying Düsseldorf, Germany-based Ceconomy AG. The Chinese e-commerce giant last showed interest in the <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43496221/jd-coms-stock-dips-as-ceconomy-deal-heats-up-in-germany-is-the-e-commerce-king-eyeing-expansion">German retailer in 2023</a>.</li>
<li>Nissan Motor Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANY#OTC">NSANY</a>) CEO Makoto Uchida informed Honda Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) CEO Toshihiro Mibe of his intention to terminate discussions <a href="https://www.benzinga.com/markets/asia/25/02/43517930/nissan-ceo-seeks-to-end-honda-merger-talks-report">on a potential merger</a>.</li>
<li>Brookfield completed its $1.7 billion acquisition of Houston-based Chemelex, a provider of electric thermal and sensing solutions. Goldman Sachs advised nVent Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVT#NYSE">NVT</a>) on the sell side.</li>
<li>Court Square Capital Partners and WindRose Health Investors completed a $1.1 billion buyout of Frisco, Texas-based infusion company Soleo Health. H.I.G. Capital.</li>
</ul>
<h2 class="wp-block-heading">Bankruptcy Block</h2>
Judge Christopher Lopez has rejected a deal that would have facilitated a second auction attempt for Alex Jones&#8216; media company, Infowars. This ruling, as reported by <a href="https://www.npr.org/2025/02/05/g-s1-46738/infowars-alex-jones-onion-bankruptcy-judge-sandy-hook">NPR</a>, provides another temporary reprieve for Jones, but delays the Sandy Hook families' efforts to collect the $1.3 billion in defamation damages awarded nearly seven years ago.
Lopez explained he couldn&#8217;t approve the deal because Infowars&#8217; parent company, Free Speech Systems (FSS), is no longer in bankruptcy. That means, he rules, its assets cannot be sold—only Jones&#8217; ownership stake in the company can be auctioned. And yet, the judge also blocked <a href="https://www.benzinga.com/media/24/11/41982446/jokes-on-jones-onion-backed-by-families-of-sandy-hook-victims-buys-info-wars">a previous offer</a> from satirical website The Onion, which had partnered with the Connecticut families to bid on Infowars. 
Moving forward, Lopez emphasized that any asset sale must be a straightforward cash deal. With this latest decision, the path to recovering damages—and potentially dismantling Jones' platform—remains uncertain.
TGI Fridays has sold 19 more restaurants as part of its ongoing Chapter 11 bankruptcy proceedings.&nbsp;Fremont, California-based Yadav Enterprises, an operator of 340 restaurants across six brands, is <a href="https://www.restaurantbusinessonline.com/financing/tgi-fridays-sells-19-restaurants-out-bankruptcy">buying</a> 16 stores for $3 million in debt. Sugarloaf Hospitality, a firm owned by former TGI Fridays CEO Ray Blanchette, is acquiring three locations for $100,000.
<h2 class="wp-block-heading">Notes From The Block</h2>
Scale Vs. Scope: This week, Bain Capital pointed out a trend in the media sector.
Media deals are becoming &#8220;predominantly cross-industry.&#8221; According to Bain&#8217;s <a href="https://www.bain.com/insights/media-and-entertainment-m-and-a-report-2025/">analysis</a>, using data from Dealogic, more than half of all media industry M&amp;A for the first three quarters of 2024 involved either a target or acquirer outside of their industry.
Here are a few callouts, cited by Bain partners Nicole Magoon, Matt Keith and Alex Egan:
<ul>
<li>The majority of Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) transactions used to be &#8220;scale&#8221; (i.e., Pixar in 2006 and 21st Century Fox in 2019); today, there&#8217;s an &#8220;increasing emphasis on scope deals.&#8221; For example, last year, Disney invested in Epic Games, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41052867/disneys-streaming-surge-epic-games-deal-among-key-growth-drivers-says-analyst">the maker of Fortnite</a>.</li>
<li>Sony Group Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) <a href="https://www.benzinga.com/general/entertainment/24/06/39313096/sony-steps-into-theater-business-with-alamo-drafthouse-purchase">purchased the theater-dinner chain</a> Alamo Drafthouse.</li>
<li>Companies are also doing deals for evergreen IP: Sony Music bought half of Michael Jackson's <a href="https://www.benzinga.com/general/entertainment/24/08/40515995/michael-jacksons-1-5b-catalog-lands-court-approval-for-sale-thriller-for-sony">publishing and recorded music catalog</a>.</li>
<li>Pophouse Entertainment acquired Kiss's catalog as well as <a href="https://www.benzinga.com/general/entertainment/24/04/38116031/sealed-with-a-kiss-rock-band-sells-legacy-for-300m-who-did-gene-simmons-get-into-bed-with">the band members' likenesses</a>. </li>
<li>Private equity funds have invested in smaller production studios with a track record of quality IP. For example, Redbird bought All3Media, seeking an enduring advantage in the video space.</li>
</ul>
Is there risk? &#8220;Acquirers in cross-sector media M&amp;A quickly learn that such deals require a different type of diligence,&#8221; the Bain partners say. &#8220;For one thing, an acquirer is likely to be less familiar with the target's industry. Also, the revenue synergies inherent in scope deals are harder to realize and underwrite than cost synergies.&#8221;
For last week&#8217;s <a href="https://www.benzinga.com/news/global/25/01/43402048/deal-dispatch-sage-and-silvus-are-up-for-sale-mrbeast-secures-20b-for-tiktok">Deal Dispatch, click here</a>.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/real-estate/25/02/43535187/gwyneth-paltrow-sells-la-home-for-22m-heres-a-look-at-actor-turned-business-moguls-pricy-property-portfolio">Gwyneth Paltrow Sells LA Home For $22M. Here&#8217;s A Look At Actor-Turned-Business-Mogul&#8217;s Pricy Property Portfolio</a></li>
</ul>
Image created using a photo from Shutterstock.

Entertainment

Asset Sales

Media

AMPS

BLCO

GRAB

NSANY

PCHM

PSFE

Sony Group Corporation American Depositary Shares

SONY

TYO:4188

Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million

Hillenbrand shares are trading lower after the company cut its FY25 earnings and revenue guidance.

The Q1 earnings report for Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) was released on Wednesday, February 5, 2025 at 04:17 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Hillenbrand beat estimated earnings by 4.0%, reporting an EPS of $0.56 versus an estimate of $0.54.
Revenue was down $66.40 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
Last quarter the company beat on EPS by $0.09 which was followed by a 12.0% increase in the share price the next day.
Here's a look at Hillenbrand's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.92</td>
<td>0.82</td>
<td>0.75</td>
<td>0.68</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.01</td>
<td>0.85</td>
<td>0.76</td>
<td>0.69</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>792.98M</td>
<td>814.55M</td>
<td>810.69M</td>
<td>777.81M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>837.60M</td>
<td>786.60M</td>
<td>785.30M</td>
<td>773.30M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Hillenbrand management provided guidance for Q2 2025, expecting earnings between $0.53 and $0.58 per share.
To track all earnings releases for Hillenbrand <a href="https://www.benzinga.com/quote/HI/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: Hillenbrand Q1

Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) reported its Q1 earnings results on Wednesday, February 5, 2025 at 04:17 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Hillenbrand beat estimated earnings by 4.0%, reporting an EPS of $0.56 versus an estimate of $0.54.
Revenue was down $66.40 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company beat on EPS by $0.09 in the previous quarter, leading to a 12.0% increase share price change the next day.
Here's a look at Hillenbrand's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.92</td>
<td>0.82</td>
<td>0.75</td>
<td>0.68</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.01</td>
<td>0.85</td>
<td>0.76</td>
<td>0.69</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>792.98M</td>
<td>814.55M</td>
<td>810.69M</td>
<td>777.81M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>837.60M</td>
<td>786.60M</td>
<td>785.30M</td>
<td>773.30M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Hillenbrand management provided guidance for Q2 2025, expecting earnings between $0.53 and $0.58 per share.
To track all earnings releases for Hillenbrand <a href="https://www.benzinga.com/quote/HI/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Hillenbrand Earnings Review: Q1 Summary

Hillenbrand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HI#NYSE">HI</a>) just disclosed its Q1 earnings on Wednesday, February 5, 2025 at 04:17 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Hillenbrand beat estimated earnings by 4.0%, reporting an EPS of $0.56 versus an estimate of $0.54.
Revenue was down $66.40 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company beat on EPS by $0.09 in the previous quarter, leading to a 12.0% increase share price change the next day.
Here's a look at Hillenbrand's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.92</td>
<td>0.82</td>
<td>0.75</td>
<td>0.68</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.01</td>
<td>0.85</td>
<td>0.76</td>
<td>0.69</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>792.98M</td>
<td>814.55M</td>
<td>810.69M</td>
<td>777.81M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>837.60M</td>
<td>786.60M</td>
<td>785.30M</td>
<td>773.30M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Hillenbrand management provided guidance for Q2 2025, expecting earnings between $0.53 and $0.58 per share.
To track all earnings releases for Hillenbrand <a href="https://www.benzinga.com/quote/HI/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Hillenbrand Q1 Earnings Assessment

Dividends

Press Releases

Hillenbrand Declares Second Quarter Dividend of $0.225 Per Share

Hillenbrand Completes Sale of Majority Stake in Milacron Injection Molding and Extrusion Business

Hillenbrand Schedules Second Quarter 2025 Earnings Call for April 30, 2025

Hillenbrand Reports Fiscal Second Quarter 2025 Results

/C O R R E C T I O N -- Hillenbrand/

Hillenbrand Declares Third Quarter Dividend of $0.225 Per Share

Hillenbrand Announces CFO Transition Plan

Hillenbrand Completes Divestiture of Minority Stake in TerraSource Holdings

Hillenbrand Announces Note Redemption, Amends Credit Agreements

Hillenbrand Schedules Third Quarter 2025 Earnings Call for August 12, 2025

Albany International Corporation Common Stock

Albany International

AirJoule Technologies Corporation - Class A Common Stock

AirJoule Technologies

Columbus McKinnon Corporation - Common Stock

Columbus McKinnon

Enerpac Tool Group

Energy Recovery

ESCO Technologies

Franklin Electric Co., Inc. - Common Stock

Franklin Electric

Graham

Gorman-Rupp

Helios Technologies

Hillman Solns

Hyster Yale

Kadant

Kennametal

Mayville Engineering Company, Inc. Common Stock

Mayville Engineering

Mueller Water Products

Nano Dimension Ltd. - American Depositary Shares

Nano Dimension

Enpro

Omega Flex

Palladyne AI

Proto Labs

Standex International Corporation Common Stock

Standex International

Timken

Tennant

Worthington Enterprises, Inc. Common Shares

Worthington Enterprises

DA Davidson

CL King

Comments

Hillenbrand

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL